机构:[1]Department of Neurosurgery, Huzhou Central Hospital, Huzhou, Zhejiang, People’s Republic of China[2]Nanchang University Medical College, Nanchang, Jiangxi, People’s Republic of China[3]Department of Gastroenterology, The 98th Hospital of Nanjing Military Command, Huzhou, Zhejiang, People’s Republic of China[4]Spleen & Stomach Institute, Guangzhou University of Traditional Chinese Medicine, Guangzhou, Guangdong, People’s Republic of China深圳市中医院深圳医学信息中心[5]Department of Neurosurgery, China-Japan Friendship Hospital, Beijing, People’s Republic of China[6]Bayi Brain Hospital, The Military General Hospital of Beijing PLA, Beijing, People’s Republic of China
In this study, we investigated the potential anticancer effects of calycosin against human glioblastoma cells, including the impacts on cell proliferation, apoptosis, and cell cycle distribution. We further studied its inhibitory activity on migration and invasion in U87 and U251 cells. Furthermore, transforming growth factor beta-mediated reductions of mesenchymal-associated genes/activators, matrix metalloproteinases-2, and -9 were detected in this process. Administration of calycosin in a glioblastoma xenograft model showed that calycosin could not only reduce tumor volume but also suppress transforming growth factor beta as well as its downstream molecules. These results revealed calycosin as a potential antitumor agent in human glioblastoma.
基金:
“National Natural Science Foundation of China” (Grant No 81573774).
第一作者机构:[1]Department of Neurosurgery, Huzhou Central Hospital, Huzhou, Zhejiang, People’s Republic of China
共同第一作者:
通讯作者:
通讯机构:[5]Department of Neurosurgery, China-Japan Friendship Hospital, Beijing, People’s Republic of China[6]Bayi Brain Hospital, The Military General Hospital of Beijing PLA, Beijing, People’s Republic of China[*1]Department of Neurosurgery, China-Japan Friendship Hospital, Yinghua East Street, Beijing 100029, People’s Republic of China[*2]Bayi Brain Hospital, The Military General Hospital of Beijing PLA , No 5 Nanmen Cang, Beijing 100700, People’s R epublic of China
推荐引用方式(GB/T 7714):
Nie Xiao-hu,Ou-yang Jia,Xing Ying,et al.Calycosin inhibits migration and invasion through modulation of transforming growth factor beta-mediated mesenchymal properties in U87 and U251 cells.[J].DRUG DESIGN DEVELOPMENT AND THERAPY.2016,10:767-779.doi:10.2147/DDDT.S90457.
APA:
Nie Xiao-hu,Ou-yang Jia,Xing Ying,Li Dan-yan,Liu Ru-en&Xu Ru-xiang.(2016).Calycosin inhibits migration and invasion through modulation of transforming growth factor beta-mediated mesenchymal properties in U87 and U251 cells..DRUG DESIGN DEVELOPMENT AND THERAPY,10,
MLA:
Nie Xiao-hu,et al."Calycosin inhibits migration and invasion through modulation of transforming growth factor beta-mediated mesenchymal properties in U87 and U251 cells.".DRUG DESIGN DEVELOPMENT AND THERAPY 10.(2016):767-779